Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting ADAM10 in Renal Diseases. | Curr Mol Med | 2023 | 36278450 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Sel1l May Contributes to the Determinants of Neuronal Lineage and Neuronal Maturation Regardless of Hrd1 via Atf6-Sel1l Signaling. | Neurochem Res | 2023 | 36074198 | PubTator, text mining | PubMed |
| Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements. | Cancer Med | 2023 | 35833755 | PubTator, text mining | PubMed |
| A classification of genes involved in normal and delayed male puberty. | Asian J Androl | 2023 | 35532554 | PubTator, text mining | PubMed |
| Mediterranean Diet and its Effect on Endothelial Function: A Meta-analysis and Systematic Review. | Ir J Med Sci | 2023 | 35192097 | PubTator, text mining | PubMed |
| Skeletal stem cells: a game changer of skeletal biology and regenerative medicine? | Life Med | 2022 | 36811113 | PubTator, text mining | PubMed |
| Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer. | Front Oncol | 2022 | 36793346 | PubTator, text mining | PubMed |
| Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection. | Front Immunol | 2022 | 36741401 | PubTator, text mining | PubMed |
| Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas. | Front Immunol | 2022 | 36726969 | PubTator, text mining | PubMed |
| Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy. | Front Genet | 2022 | 36712858 | PubTator, text mining | PubMed |
| The roles of chemokines following intracerebral hemorrhage in animal models and humans. | Front Mol Neurosci | 2022 | 36704330 | PubTator, text mining | PubMed |
| Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. | Front Oncol | 2022 | 36703796 | PubTator, text mining | PubMed |
| Sentinel surveillance and epidemiology of Clostridioides difficile in Denmark, 2016 to 2019. | Euro Surveill | 2022 | 36695439 | PubTator, text mining | PubMed |
NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer. | Bioengineered | 2022 | 36694434 | PubTator, text mining | PubMed |
| Acupuncture treatment of a pregnant patient with Bell's palsy in the third trimester: Case report. | Front Neurol | 2022 | 36686504 | PubTator, text mining | PubMed |
| Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19. | Front Immunol | 2022 | 36685582 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals heterogeneity and convergence of the tumor microenvironment in colorectal cancer. | Front Immunol | 2022 | 36685571 | PubTator, text mining | PubMed |
| Molecular Epidemiology of Group B Streptococcus Colonization in Egyptian Women. | Microorganisms | 2022 | 36677330 | PubTator, text mining | PubMed |
| The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. | Expert Opin Ther Targets | 2022 | 36657483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=24